Cited by 750Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaPharmaceutical and Antibiotic Environmental Impacts

Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis

Open access
Collignon, Peter, Beggs, John J, Walsh, Timothy R, Gandra, Sumanth, Laxminarayan, Ramanan·2018·The Lancet Planetary Health

Abstract

Background Understanding of the factors driving global antimicrobial resistance is limited. We analysed antimicrobial resistance and antibiotic consumption worldwide versus many potential contributing factors. Methods Using three sources of data (ResistanceMap, the WHO 2014 report on antimicrobial resistance, and contemporary publications), we created two global indices of antimicrobial resistance for 103 countries using data from 2008 to 2014: Escherichia coli resistance—the global average prevalence of E coli bacteria that were resistant to third-generation cephalosporins and fluoroquinolones, and aggregate resistance—the combined average prevalence of E coli and Klebsiella spp resistant to third-generation cephalosporins, fluoroquinolones, and carbapenems, and meticillin-resistant Staphylococcus aureus . Antibiotic consumption data were obtained from the IQVIA MIDAS database. The World Bank DataBank was used to obtain data for governance, education, gross domestic product (GDP) per capita, health-care spending, and community infrastructure (eg, sanitation). A corruption index was derived using data from Transparency International. We examined associations between antimicrobial resistance and potential contributing factors using simple correlation for a univariate analysis and a logistic regression model for a multivariable analysis. Findings In the univariate analysis, GDP per capita, education, infrastructure, public health-care spending, and antibiotic consumption were all inversely correlated with the two antimicrobial resistance indices, whereas higher temperatures, poorer governance, and the ratio of private to public health expenditure were positively correlated. In the multivariable regression analysis (confined to the 73 countries for which antibiotic consumption data were available) considering the effect of changes in indices on E coli resistance ( R 2 0·54) and aggregate resistance ( R 2 0·75), better infrastructure (p=0·014 and p=0·0052) and better governance (p=0·025 and p<0·0001) were associated with lower antimicrobial resistance indices. Antibiotic consumption was not significantly associated with either antimicrobial resistance index in the multivariable analysis (p=0·64 and p=0·070). Interpretation Reduction of antibiotic consumption will not be sufficient to control antimicrobial resistance because contagion—the spread of resistant strains and resistance genes—seems to be the dominant contributing factor. Improving sanitation, increasing access to clean water, and ensuring good governance, as well as increasing public health-care expenditure and better regulating the private health sector are all necessary to reduce global antimicrobial resistance. Funding None.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2542-5196(18)30186-4

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
  2. Wang Y, Zhang R, Li J, et al. Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production. Nat Microbiol 2017; 2: 16260.
  3. Robinson TP, Bu DP, Carrique-Mas J, et al. Antibiotic resistance is the quintessential One Health issue. Trans Royal Soc Trop Med Hyg 2016; 110: 377-80.
  4. Collignon P. The importance of a One Health approach to preventing the development and spread of antibiotic resistance. Curr Top Microbiol Immunol 2013; 366: 19-36.
  5. Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M. Achieving global targets for antimicrobial resistance. Science 2016; 353: 874-75.
  6. Collignon P. Antibiotic resistance: are we all doomed? Intern Med J 2015; 45: 1109-15.
  7. Makuta I, O'Hare B. Quality of governance, public spending on health and health status in sub-Saharan Africa: a panel data regression analysis. BMC Public Health 2015; 15: 932.
  8. Feinstein L, Sabates R, Anderson TM, Sorhaindo A, Hammond C. What are the effects of education on health? Proceedings of the Copenhagen Symposium. 2006. http://www.oecd.org/education/ innovation-education/37425753.pdf (accessed April 21, 2018).
  9. Wagstaff A. Poverty and health sector inequalities. Bull World Health Org 2001; 80: 97-105.
  10. Goossens H, Ferech M, Stichele RM, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
  11. Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016; 387: 176-87.
  12. Walsh TR, Wu Y. China bans colistin as feed addictive (growth promoter) in animals. Lancet Infect Dis 2016; 16: 1102-03.
  13. Aidara-Kane A, Angulo FJ, Conly JM, et al. WHO Guideline Development Group: World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals. Antimicrob Resist Infect Control 2018; 7: 7.
  14. Shen Z, Wang Y, Shen Y, Shen J, Wu C. Early emergence of mcr-1 in Escherichia coli from food-producing animals. Lancet Infect Dis 2016; 16: 293.
  15. Collignon P, Athukorala PC, Senanayake S, Khan F. Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PLoS One 2015; 10: e0116746.
  16. Högberg LD, Muller A, Zorzet A, Monnet DL, Cars O. Antibiotic use worldwide. Lancet Infect Dis 2014; 14: 1179-80.
  17. Hunter PR, MacDonald AM, Carter RC. Water supply and health. PLoS Med 2010; 7: e1000361.
  18. Finley RL, Collignon P, Larsson DG, et al. The scourge of antibiotic resistance: the important role of the environment. Clin Infect Dis 2013; 57: 704-10.
  19. Kliemann BS, Levin AS, Moura ML, Boszczowski I, Lewis JJ. Socioeconomic determinants of antibiotic consumption in the state of São Paulo, Brazil: the effect of restricting over-the-counter sales. PLoS One 2016; 11: e0167885.
  20. Onwugamba FC, Fitzgerald JR, Rochon K, et al. The role of 'filth flies' in the spread of antimicrobial resistance. Travel Med Infect Dis 2018; 22: 8-17.
  21. Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Nat Acad Sci USA 2015; 112: 5649-54.

Cited by

Sorted by citations

Authors
Collignon, P., Beggs, J. J., Walsh, T. R., Gandra, S., & Laxminarayan, R.
Affiliations
  • Australian National University (AU)
  • Cardiff University (GB)
  • Center for Disease Dynamics, Economics & Policy (US)
  • Princeton University (US)
Corresponding author
Collignon, Peter
Venue
The Lancet Planetary Health
Publisher
Elsevier BV
Published
2018-09
Volume
2
Issue
9
Pages
e398-e405
ISSN
2542-5196 (ISSN-L)
OpenAlex
W2889006122
Cited by
750
References
2
Citations by year
2026: 76 · 2025: 103 · 2024: 114 · 2023: 92 · 2022: 105 · 2021: 107 · 2020: 84 · 2019: 63 · 2018: 5
FWCI
39.59
Type
journal article
Language
en
Open access
Locations
  • The Lancet Planetary Health (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • ANU Open Research (Australian National University) (submittedVersion, cc-by-nc-nd)
Funders
  • Centers for Disease Control and Prevention
  • Government of the United Kingdom
  • Bill and Melinda Gates Foundation (16IPA1609427)
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
Keywords
antimicrobial resistance, Klebsiella, third-generation cephalosporin resistance, fluoroquinolone resistance, carbapenem resistance, methicillin-resistant Staphylococcus aureus, antibiotic use, socioeconomic factors, governance, sanitation, public health expenditure, GDP per capita, corruption, resistance gene transmission
MeSH terms
Anti-Bacterial Agents, Escherichia coli, Humans, Klebsiella, Health Knowledge, Attitudes, Practice, Socioeconomic Factors, Multivariate Analysis, Drug Resistance, Bacterial, Methicillin-Resistant Staphylococcus aureus, Anthropology, Medical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review